Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.840
-0.001 (-0.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gossamer Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 190 | 206 | 205 | 854 | 701 | 953 | |
Market Cap Growth | 18.92% | 0.56% | -76.06% | 21.87% | -26.45% | - | |
Enterprise Value | 67 | 93 | 118 | 673 | 329 | 547 | |
Last Close Price | 0.84 | 0.91 | 2.17 | 11.31 | 9.67 | 15.63 | |
PB Ratio | 3.52 | 3.28 | 16.94 | 7.03 | 2.19 | 2.70 | |
P/TBV Ratio | 4.12 | 3.28 | 16.94 | 7.03 | 2.19 | 2.70 | |
Debt / Equity Ratio | 3.76 | 3.38 | 18.69 | 1.53 | 0.57 | 0.11 | |
Quick Ratio | 6.53 | 5.74 | 5.19 | 8.16 | 13.27 | 10.92 | |
Current Ratio | 6.74 | 5.94 | 5.32 | 8.32 | 13.51 | 11.09 | |
Return on Equity (ROE) | -90.26% | -480.50% | -343.53% | -105.85% | -72.30% | -63.18% | |
Return on Assets (ROA) | -11.24% | -37.17% | -44.34% | -30.58% | -27.25% | -34.26% | |
Return on Capital (ROIC) | -13.58% | -42.33% | -50.17% | -33.30% | -29.36% | -37.39% | |
Earnings Yield | -37.64% | -87.42% | -112.15% | -27.39% | -34.71% | -18.92% | |
FCF Yield | -0.74% | -77.38% | -91.64% | -22.29% | -25.37% | -15.51% | |
Buyback Yield / Dilution | -88.97% | -80.46% | -13.00% | -9.24% | -25.16% | -741.53% | |
Total Shareholder Return | -88.97% | -80.46% | -13.00% | -9.24% | -25.16% | -741.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.